Invention Grant
- Patent Title: Compounds for the treatment of hepatitis C
-
Application No.: US13755971Application Date: 2013-01-31
-
Publication No.: US09303020B2Publication Date: 2016-04-05
- Inventor: Kap-Sun Yeung , John F. Kadow
- Applicant: Bristol-Myers Squibb Company
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent James Epperson
- Main IPC: C07D405/14
- IPC: C07D405/14 ; C07D405/04
Abstract:
The disclosure provides compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
Public/Granted literature
- US20130203775A1 Novel Compounds for the Treatment of Hepatitis C Public/Granted day:2013-08-08
Information query
